Basic Information
Bioxyne Limited, established in 2000, focuses on the research and development of health care products with clinical efficacy, particularly in gastrointestinal health and immune system support. Holding the patented probiotic product PCC®, the company has a manufacturing and distribution agreement with Chr. Hansen in Denmark and a distribution partnership with high-end consumer goods marketing enterprises such as Nu Skin Group in the United States.
Bioxyne Limited
Sydney,NewSouthWales,Australia
101~500 people
January 01, 2005
info@bioxyne.com

